Qi-di Huang

Suppression of MD 2 inhibits breast cancer in vitro and in vivo

G. Guo, Jie Zhou, W. Fu, 2021 .

VASN promotes YAP/TAZ and EMT pathway in thyroid carcinogenesis in vitro.

Yizuo Chen, Er-jie Xia, Adheesh Bhandari, 2019, American journal of translational research.

Real-world outcomes for Chinese breast cancer patients with tumor location of central and nipple portion

W. Fu, G. Guo, K. Lu, 2022, Frontiers in Surgery.

The pan‐cancer analysis of the oncogenic role of FAM72A as a BRCA prognostic biomarker and immunotherapeutic target

Yiying Xu, Yanyan Shen, Adheesh Bhandari, 2023, Environmental toxicology.

miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis

Xiaohua Zhang, J. You, Shu-rong Zheng, 2016, Tumor Biology.

Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis

Wei Zhang, Guan-li Huang, Xiao-qu Hu, 2012, Oncology reports.

circGFRA1 affects the sensitivity of triple negative breast cancer cells to paclitaxel via the miR-361-5p/TLR4 pathway.

Zhi-hai Zheng, Zhong-tao Zhang, G. Guo, 2021, Journal of biochemistry.

SEC61G regulates breast cancer cell proliferation and metastasis by affecting the Epithelial-Mesenchymal Transition

Adheesh Bhandari, Lingli Jin, Qi-di Huang, 2022, Journal of Cancer.

LncRNA PRKCQ‐AS1 regulates paclitaxel resistance in triple‐negative breast cancer cells through miR‐361‐5p/PIK3C3 mediated autophagy

Guilong Guo, Weida Fu, Shu-rong Zheng, 2023, Clinical and experimental pharmacology & physiology.